Owner Arena Pharmaceuticals, Inc.

Inventors Adams, John W.; Connolly, Daniel T.

Agent FB Rice

Pub. Number AU-B-2003259237

PCT Number PCT/US03/23296

PCT Pub. Number WO2004/013285

Priority 60/400,774 01.08.02 US

Filing date 25 July 2003

Wipo publication date 23 February 2004

Acceptance publication date 6 January 2011

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/14 (2006.01) Enzymes, e.g. ligases (6.) - Hydrolases (3.)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms